Alumis | SC 13D:超过5%持股股东披露文件-Samsara BioCapital, L.P.(6.9%),Samsara BioCapital GP, LLC(6.9%)等
Alumis | 4/A:持股变动声明(修正)-董事 AKKARAJU SRINIVAS
Alumis | D:发行公告
Alumis | SC 13G:超过5%持股股东披露文件-venBio Global Strategic Fund IV, L.P.(6.3%),venBio Global Strategic GP IV, LLC(6.3%)等
Alumis | SC 13D:超过5%持股股东披露文件-James B. Tananbaum (“Tananbaum”)(29.2%),Foresite Capital Management V, LLC (“FCM V”)(11.1%)等
Alumis | 4:持股变动声明-股东 Foresite Labs, LLC
Alumis | 4:持股变动声明-股东 Foresite Capital Management V, LLC
Alumis | 4:持股变动声明-董事 Tananbaum James B.
Alumis | SC 13D:超过5%持股股东披露文件-AyurMaya Capital Management Company, LP(22.57%),David E. Goel(22.57%)
Alumis | 4:持股变动声明-董事 AyurMaya Capital Management Company, LP
Alumis | 4:持股变动声明-高管 Klein Sara
Alumis | 4:持股变动声明-高管 Schroer John R.
Alumis | 4:持股变动声明-董事 Machado Patrick
Alumis | 4:持股变动声明-董事 Srivastava Sapna
Alumis | 4:持股变动声明-董事 Yao Zhengbin
Alumis | 4:持股变动声明-董事 AKKARAJU SRINIVAS
Alumis | 4:持股变动声明-高管 Richardson Derrick
Alumis | 4:持股变动声明-高管 Bradley Mark Christopher
Alumis | 4:持股变动声明-高管 Drappa Jorn
Alumis | 4:持股变动声明-高管 Goldstein David M